
Novo and existing backer GV participated in a round that lifted the heart disease drug developer's overall funding to more than $215m.
The last-mile delivery platform has amassed $121m in overall funding having completed a series E round featuring existing investor Google.
Tencent took part in a round sized at nearly $100m for the English language learning platform, which counts Bertelsmann among its earlier investors.
HealthQuest Capital supplied $75m for the medical test provider, which counts The Chernin Group as an investor, at a flat $1.3bn valuation.
DA Consortium, Gree Ventures, Hakuhodo DY Media Partners and SBI Group were among the backers in a $48.2m round for the marketing, media and ride hailing service operator.
The mobility service provider will use the $50.1m cash it secured from SoftBank and Didi Chuxing to expand from Chinese tourists to local Japanese users.
H&M Co:Lab reinvested in the last-mile delivery service as part of a round that will support its international expansion and the strengthening of its technology.
Verizon Ventures was among the investors that added $25m to a round already featuring Dell Technologies Capital, MS&AD Ventures and NTT Docomo Ventures.
UPMC-backed cancer immunotherapy developer BlueSphere Bio has attracted an initial $45.6m in series B funding towards a $105m target for its close.
Wind, Shanghai Zhangjiang Hi-tech Park Development and Chengxin Credit Ratings all backed the mapping technology provider's series A-plus round.